ornithine has been researched along with Cognitive Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iga, JI; Mawatari, K; Mori, T; Nakayama, T; Numata, S; Ohmori, T; Ozaki, T; Shimizu, H; Tachibana, A; Takahashi, A; Ueno, SI; Yoshino, Y | 1 |
| Arias, N; Hadjihambi, A; Jalan, R; Sheikh, M | 1 |
1 review(s) available for ornithine and Cognitive Dysfunction
| Article | Year |
|---|---|
Hepatic encephalopathy: a critical current review.
Topics: Albumins; Ammonia; Anti-Bacterial Agents; Bile Acids and Salts; Brain; Brain Edema; Cognitive Dysfunction; Dipeptides; Energy Metabolism; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Ornithine; Portasystemic Shunt, Surgical; Prognosis; Psychometrics; Severity of Illness Index; Synaptic Transmission | 2018 |
1 other study(ies) available for ornithine and Cognitive Dysfunction
| Article | Year |
|---|---|
Metabolomic alterations in the blood plasma of older adults with mild cognitive impairment and Alzheimer's disease (from the Nakayama Study).
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Betaine; Biomarkers; Cognitive Dysfunction; Humans; Lysine; Ornithine; Plasma; RNA, Messenger; Thymine | 2022 |